Healthcare provider profile · identity verified

Todd S. Martin, MD

Family Practice · SAN DIEGO, CA · NPI 1740338573

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	442	157
Levothyroxine Sodium	Levothyroxine Sodium	283	98
Rosuvastatin Calcium	Rosuvastatin Calcium	280	100
Amlodipine Besylate	Amlodipine Besylate	263	95
Losartan Potassium	Losartan Potassium	211	67
Lisinopril	Lisinopril	183	69
Metformin Hcl	Metformin Hcl	170	61
Potassium Chloride	Potassium Chloride	150	47
Omeprazole	Omeprazole	145	47
Hydrochlorothiazide	Hydrochlorothiazide	128	41
Atenolol	Atenolol	116	36
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	116	28
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	105	39
Terazosin Hcl	Terazosin Hcl	105	31
Pradaxa	Dabigatran Etexilate Mesylate	104	26
Simvastatin	Simvastatin	100	33
Gabapentin	Gabapentin	99	40
Albuterol Sulfate Hfa	Albuterol Sulfate	92	38
Metoprolol Tartrate	Metoprolol Tartrate	81	28
Tamsulosin Hcl	Tamsulosin Hcl	81	28
Trazodone Hcl	Trazodone Hcl	74	24
Glipizide	Glipizide	67	24
Meloxicam	Meloxicam	64	28
Metformin Hcl Er	Metformin Hcl	58	27
Famotidine	Famotidine	57	20
Spironolactone	Spironolactone	57	21
Pantoprazole Sodium	Pantoprazole Sodium	56	18
Furosemide	Furosemide	54	22
Alendronate Sodium	Alendronate Sodium	52	22
Jardiance	Empagliflozin	50	23
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	50	suppressed
Allopurinol	Allopurinol	49	16
Clopidogrel	Clopidogrel Bisulfate	49	18
Sertraline Hcl	Sertraline Hcl	49	22
Triamcinolone Acetonide	Triamcinolone Acetonide	48	27
Donepezil Hcl	Donepezil Hcl	37	11
Hydrocortisone	Hydrocortisone	36	suppressed
Morphine Sulfate Er	Morphine Sulfate	34	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	33	15
Ibuprofen	Ibuprofen	33	11
Metoprolol Succinate	Metoprolol Succinate	33	12
Ezetimibe	Ezetimibe	30	12
Humulin N	Insulin Nph Human Isophane	30	11
Wixela Inhub	Fluticasone Propion/Salmeterol	29	13
Duloxetine Hcl	Duloxetine Hcl	25	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	23	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Finasteride	Finasteride	22	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Eliquis	Apixaban	20	suppressed
Tramadol Hcl	Tramadol Hcl	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Mupirocin	Mupirocin	19	suppressed
Spiriva Respimat	Tiotropium Bromide	19	suppressed
Xarelto	Rivaroxaban	18	suppressed
Prednisone	Prednisone	17	16
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	15
Arexvy	Rsvpref3 Antigen/As01e/Pf	16	16
Chlorthalidone	Chlorthalidone	16	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	16	11
Digoxin	Digoxin	16	suppressed
Metronidazole	Metronidazole	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	14
Acyclovir	Acyclovir	14	suppressed
Alvesco	Ciclesonide	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	12	suppressed
Citalopram Hbr	Citalopram Hydrobromide	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	11	11
Azithromycin	Azithromycin	11	11
Fluticasone Propionate	Fluticasone Propionate	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Ozempic	Semaglutide	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error